Russia files Sputnik V vaccine registration in Europe
Russia's sovereign wealth fund RDIF has filed for registration of the Sputnik V Covid-19 vaccine in the European Union and expects it to be reviewed in February, as Moscow seeks to speed up its availability worldwide.
The official account promoting the vaccine tweeted the latest development on Wednesday, moving it a step closer for approval as countries across the world plan massive vaccine rollouts to stem the pandemic.
The Sputnik V vaccine has been approved in Argentina, Belarus, Serbia and several other countries.
The Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews.
While vaccines from Pfizer Inc and Moderna Inc have started rolling out in several countries, experts have said...